LENZ THERAPEUTICS INC
LENZNASDAQ🏆 #3954 by market capUS Equity
$3.19—
Last available close · quote unavailableTrack LENZ
Get earnings, price moves & breaking news on Telegram
24h—
7d▼ 1.7%
14d▼ 11.2%
30d▼ 17.5%
ytd▼ 80.1%
1y▼ 89.6%
🏦Market Cap
$101M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
4.6x
Fair
Otter Score
—
Insufficient data
Trading Snapshot
- Day Range
- —
- 52-Week Range
- $3.06 – $32.92
- Volume (shares)
- —
- Avg Volume (shares)
- —
- Shares Outstanding
- 31.4M
- Next Earnings
- —
Fundamentals Snapshot
- Annual Revenue
- $19M
- Last Q Revenue
- $5M
- P/E Ratio
- —
- P/S Ratio
- 4.6x
- EPS (TTM)
- $-4.08
- Dividend Yield
- —
- Dilution (1yr)
- +13.0%
LENZ THERAPEUTICS INC
LENZFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$19M
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
96.3%
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$91M▲ +55.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$70M▲ +16.9% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
31.1M▲ +13.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$24M▲ +$6M YoY
StockOtter · stockotter.spaceAbout LENZ THERAPEUTICS INC
LENZ Therapeutics, Inc. is a biopharmaceutical firm whose primary mission involves the advancement and commercialization of new treatments designed to enhance vision for individuals in the United States. The company's portfolio features two investigational products, LNZ100 and LNZ101, both of which are currently undergoing late-stage Phase III clinical trials as potential solutions for presbyopia. Corporate operations for LENZ Therapeutics are situated in Del Mar, California.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.
Latest News & Updates
News unavailable.